Budapest, Hungary

Miklos Riesz

This inventor holds 1 USPTO granted patent. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Miklos Riesz

Introduction

Miklos Riesz, a notable inventor based in Budapest, Hungary, has made significant strides in the field of pharmaceuticals. With a focus on advancements in chemical processes, he has developed novel compounds that hold promise for medical applications.

Latest Patents

Miklos Riesz is credited with one patent titled "Nintrovincaminic acid derivatives having pharmaceutical utility." This invention pertains to a new process for preparing novel racemic and optically active 9- or 11-nitroapovincaminic acid derivatives of a specific general formula. This research contributes valuable insights into pharmaceutical chemistry and opens avenues for developing effective medical treatments.

Career Highlights

Miklos Riesz is currently associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent company known for its innovative approaches in pharmaceutical manufacturing. His role has enabled him to focus on groundbreaking research, leading to the development of new and effective pharmaceutical compounds.

Collaborations

Throughout his career, Miklos has collaborated with esteemed colleagues, including Andras Vedres and Csaba Szantay. These collaborative efforts have played a vital role in enhancing the quality and scope of his research, fostering innovation in pharmaceutical applications.

Conclusion

Miklos Riesz's contributions to the field of pharmaceutical chemistry showcase the vital role of inventors in shaping healthcare solutions. His innovative work, anchored in rigorous scientific research, continues to inspire advancements that may significantly impact future medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…